Key Record Dates
ClinicalTrials.gov Identifier: | NCT05736731 |
---|---|
Brief Title: | A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Subjects With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression (EVEREST-1) |
First Submitted : | January 30, 2023 |
First Submitted that Met QC Criteria : | February 10, 2023 |
First Posted : | February 21, 2023 |
Last Update Submitted that Met QC Criteria : | April 7, 2024 |
Last Update Posted : | April 9, 2024 |